Pharmacy Tied to Meningitis Outbreak Received Prior Warnings
New England Compounding Center (NECC), the pharmacy that produced tainted steroid back injections that have been linked to a nationwide fungal meningitis outbreak, received prior warnings about their operating practices, several news outlets are reporting.
NECC Received Warnings in 2006
- The Massachusetts Board of Registration in Pharmacy sent NECC a warning letter in 2006 claiming the company was acting more like a drug manufacturing firm than a compounding pharmacy.
- NECC agreed to a third party inspection of its drug compounding practices, sterility, environmental monitoring, cleaning and sanitizing, and quality control programs.
- The investigation resulted in a consent agreement between NECC and the state's Board of Registration in Pharmacy which called for more audits and a one year probation period.
- The FDA sent NECC a separate warning letter in 2006 alleging several other regulatory violations, including one related to the repackaging of the injectable cancer drug, Avastin.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division has extensive knowledge and resources in order to represent our clients efficiently and aggressively.
If you or someone you love contracted fungal meningitis after being injected with Methylprednisolone Acetate produced at New England Compounding Pharmacy, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.